These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16205018)

  • 21. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studies.
    Bex M; Buysschaert M; De Leeuw I; De Schepper J; Fery F; Hermans MP; Keymeulen B; Lauvaux JP; Letiexhe M; Mathieu C; Nobels FR; Rottiers R; Scheen A; Schmitt H; Van Crombrugge P; Van Gaal L
    Acta Clin Belg; 1999 Oct; 54(5):241-5. PubMed ID: 10555381
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
    Herz M
    Int J Clin Pract Suppl; 1999 Jul; 104():8-13; discussion 18-20. PubMed ID: 12669732
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biphasic insulin aspart (NovoMix 50)].
    Radermecker RP; Scheen AJ
    Rev Med Liege; 2008 Nov; 63(11):688-92. PubMed ID: 19112996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin lispro--a review.
    Muzaffer Z; Iqbal A; Ristic S
    J Pak Med Assoc; 1998 Jul; 48(7):212-4. PubMed ID: 10067027
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of postprandial Humalog in toddlers with diabetes.
    Rutledge KS; Chase HP; Klingensmith GJ; Walravens PA; Slover RH; Garg SK
    Pediatrics; 1997 Dec; 100(6):968-72. PubMed ID: 9374566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment.
    Aristides M; Weston AR; FitzGerald P; Le Reun C; Maniadakis N
    Value Health; 2004; 7(4):442-54. PubMed ID: 15449636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The short-acting insulin analog Lispro (Humalog) in the treatment of diabetes--comparison of preprandial and postprandial administration and comparison with treatment using Humulin R].
    Perusicová J; Svehelka JM
    Vnitr Lek; 1998 Jul; 44(7):409-14. PubMed ID: 9748877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin lispro].
    Matsuda A
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():485-91. PubMed ID: 12387039
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The efficacy of the ultrashort-term action insulin-lispro preparation "humalog" and the antioxidant mexidol in the complex treatment of type I diabetes in infants and adolescents].
    Masiagina EN; Balykova LA; Mukhina LIu; Markelova IA
    Eksp Klin Farmakol; 2008; 71(1):39-42. PubMed ID: 18365486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog in subjects with type 1 diabetes.
    Kapitza C; Nowotny I; Lehmann A; Bergmann K; Rotthaeuser B; Nosek L; Becker RHA
    Diabetes Obes Metab; 2017 May; 19(5):622-627. PubMed ID: 27987252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
    Koivisto VA; Tuominen JA; Ebeling P
    Diabetes Care; 1999 Mar; 22(3):459-62. PubMed ID: 10097929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE; Korzon-Burakowska A; Woodworth JR; Evans M; Hopkins D; Janes JM; Amiel SA
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.